Craig Bijou
Stock Analyst at B of A Securities
(3.84)
# 715
Out of 4,711 analysts
58
Total ratings
61.29%
Success rate
64.29%
Average return
Main Sectors:
Stocks Rated by Craig Bijou
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BLCO Bausch + Lomb | Reinstates: Underperform | $18 | $18.00 | - | 2 | Dec 12, 2024 | |
| GMED Globus Medical | Maintains: Underperform | $55 → $80 | $82.63 | -3.18% | 3 | Nov 6, 2024 | |
| IART Integra LifeSciences Holdings | Maintains: Underperform | $26 → $18 | $21.80 | -17.43% | 13 | Oct 7, 2024 | |
| ITGR Integer Holdings | Maintains: Buy | $135 → $145 | $133.67 | +8.48% | 3 | Oct 1, 2024 | |
| MMSI Merit Medical Systems | Maintains: Neutral | $92 → $103 | $98.22 | +4.87% | 3 | Sep 16, 2024 | |
| HAE Haemonetics | Initiates: Neutral | $85 | $75.44 | +12.67% | 1 | Sep 11, 2024 | |
| PRCT PROCEPT BioRobotics | Maintains: Buy | $80 → $94 | $81.17 | +15.81% | 3 | Aug 22, 2024 | |
| GEHC GE HealthCare Technologies | Maintains: Neutral | $94 → $86 | $78.91 | +8.98% | 2 | May 1, 2024 | |
| COO The Cooper Companies | Initiates: Buy | $95 | $93.44 | +1.67% | 1 | Oct 30, 2023 | |
| TFX Teleflex | Maintains: Neutral | $265 | $178.16 | +48.74% | 4 | Aug 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $30 → $25 | $10.03 | +149.25% | 1 | Mar 9, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $43 → $36 | $13.25 | +171.70% | 2 | Jan 18, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $23 → $45 | $8.70 | +417.24% | 3 | May 13, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $1 → $8 | $0.58 | +1,279.07% | 2 | Mar 25, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $60 → $30 | $15.27 | +96.46% | 5 | Mar 24, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $17 → $13 | $9.24 | +40.69% | 2 | Mar 24, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $48 → $42 | $17.43 | +140.96% | 3 | Feb 25, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $207 → $230 | $524.43 | -56.14% | 1 | Jan 10, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $190 → $230 | $364.60 | -36.92% | 4 | Jul 26, 2019 |
Bausch + Lomb
Dec 12, 2024
Reinstates: Underperform
Price Target: $18
Current: $18.00
Upside: -
Globus Medical
Nov 6, 2024
Maintains: Underperform
Price Target: $55 → $80
Current: $82.63
Upside: -3.18%
Integra LifeSciences Holdings
Oct 7, 2024
Maintains: Underperform
Price Target: $26 → $18
Current: $21.80
Upside: -17.43%
Integer Holdings
Oct 1, 2024
Maintains: Buy
Price Target: $135 → $145
Current: $133.67
Upside: +8.48%
Merit Medical Systems
Sep 16, 2024
Maintains: Neutral
Price Target: $92 → $103
Current: $98.22
Upside: +4.87%
Haemonetics
Sep 11, 2024
Initiates: Neutral
Price Target: $85
Current: $75.44
Upside: +12.67%
PROCEPT BioRobotics
Aug 22, 2024
Maintains: Buy
Price Target: $80 → $94
Current: $81.17
Upside: +15.81%
GE HealthCare Technologies
May 1, 2024
Maintains: Neutral
Price Target: $94 → $86
Current: $78.91
Upside: +8.98%
The Cooper Companies
Oct 30, 2023
Initiates: Buy
Price Target: $95
Current: $93.44
Upside: +1.67%
Teleflex
Aug 3, 2023
Maintains: Neutral
Price Target: $265
Current: $178.16
Upside: +48.74%
Mar 9, 2022
Maintains: Buy
Price Target: $30 → $25
Current: $10.03
Upside: +149.25%
Jan 18, 2022
Maintains: Buy
Price Target: $43 → $36
Current: $13.25
Upside: +171.70%
May 13, 2020
Reiterates: Overweight
Price Target: $23 → $45
Current: $8.70
Upside: +417.24%
Mar 25, 2020
Maintains: Overweight
Price Target: $1 → $8
Current: $0.58
Upside: +1,279.07%
Mar 24, 2020
Maintains: Neutral
Price Target: $60 → $30
Current: $15.27
Upside: +96.46%
Mar 24, 2020
Reiterates: Overweight
Price Target: $17 → $13
Current: $9.24
Upside: +40.69%
Feb 25, 2020
Maintains: Neutral
Price Target: $48 → $42
Current: $17.43
Upside: +140.96%
Jan 10, 2020
Reiterates: Overweight
Price Target: $207 → $230
Current: $524.43
Upside: -56.14%
Jul 26, 2019
Maintains: Neutral
Price Target: $190 → $230
Current: $364.60
Upside: -36.92%